Previous 10 | Next 10 |
Overview The medical device company Globus Medical (NYSE: GMED ) has beaten The Street's Q2 EPS estimates, scoring a surprise of $0.07 earnings per share exiting the second quarter. Revenues also surpassed expectations by 49.3% over this most recent period and consequently, the stock has ral...
Orthofix Medical, Inc. (OFIX) Q2 2020 Results Conference Call August 06, 2020 08:30 AM ET Company Participants Alexa Huerta - Senior Director, IR and Finance Jon Serbousek - President and CEO Doug Rice - CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann ...
Image source: The Motley Fool. Orthofix Medical Inc (NASDAQ: OFIX) Q2 2020 Earnings Call Aug 6, 2020 , 8:30 a.m. ET Operator Continue reading
Orthofix (NASDAQ: OFIX ) : Q2 GAAP EPS of -$0.96 beats by $0.05 . Revenue of $73.1M (-36.9% Y/Y) beats by $22.37M . Press Release More news on: Orthofix Medical Inc., Earnings news and commentary, Healthcare stocks news,
Net sales of $73.1 million, a decrease of 37% compared to prior year on a reported and constant currency basis Record Motion Preservation sales quarter of $3.6 million in the U.S., an increase of 24% sequentially New product innovation cadence building momentum with new r...
Orthofix Medical Inc. (NASDAQ:OFIX) today announced that President and Chief Executive Officer Jon Serbousek will present at the Canaccord Genuity 40 th Annual Growth Conference on Thursday, August 13, 2020 at 2:30 p.m. ET. The conference will be held in a virtual meeting format. A live ...
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it plans to release financial results for the second quarter 2020 before market open on Thursday, August 6, 2020. Jon Serbousek, President and Chief Exe...
Orthofix Medical (NASDAQ: OFIX ) announces FDA clearance and CE Mark certification of its JuniOrtho fixation system for the treatment of advanced deformity and trauma reconstruction of the lower extremities in pediatric patients. More news on: Orthofix Medical Inc., Healthcare stocks n...
Orthofix Medical Inc . (NASDAQ:OFIX), a global medical device company focused on musculoskeletal healing products, today announced it has received the U.S. Food and Drug Administration (FDA) 510(k) clearance and European CE Mark approval for the JuniOrtho ® Plating System . Created sp...
Orthofix Medical (NASDAQ: OFIX ) announces the FDA 510(k) clearance and the first patient implants of the FIREBIRD SI Fusion System. More news on: Orthofix Medical Inc., Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Orthofix Medical Inc. Company Name:
OFIX Stock Symbol:
NASDAQ Market:
Orthofix Medical Inc. Website:
Wednesday, August 14, 2024 at 2:30 pm Eastern Time Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that the Company will participate in Canaccord Genuity's 44th Annual Growth Conference in Boston. Management is scheduled to pre...
Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Stephanie Walsh as Chief Human Resources Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240716004...
Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the 510(k) clearance and first U.S. implant of the Fitbone ™ Transport and Lengthening System. Used to treat large bone defects in the femur and tibia due to trauma, infectious or ma...